Inactive Instrument

News Neurotrope Inc Other OTC

Equities

US64129T1088

End-of-day quote Other OTC Other stock markets
- ^USD	-

2020	Neurotrope, Inc. completed the spin-off of Neurotrope Bioscience, Inc.	CI
2020	Metuchen Pharmaceuticals LLC completed the acquisition of Neurotrope, Inc. from Intracoastal Capital LLC and others in a reverse merger transaction.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Neurotrope, Inc. completed the spin-off of Neurotrope Bioscience, Inc.	20-12-01	CI
Metuchen Pharmaceuticals LLC completed the acquisition of Neurotrope, Inc. from Intracoastal Capital LLC and others in a reverse merger transaction.	20-11-30	CI
NEUROTROPE, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	20-11-25	AQ
NEUROTROPE, INC. : Other Events (form 8-K)	20-11-24	AQ
NEUROTROPE, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	20-11-20	AQ
NEUROTROPE : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	20-11-09	AQ
Neurotrope, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-09	CI
Neurotrope, Inc Announces Dosing of the First Patient in Its Ongoing, Long-Term Phase 2 Study of Bryostatin-1 for the Treatment of Alzheimer's Disease	20-10-06	CI
NEUROTROPE, INC. : Other Events (form 8-K)	20-09-30	AQ
NEUROTROPE, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	20-09-30	AQ
NEUROTROPE : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	20-08-10	AQ
Neurotrope, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-10	CI
NEUROTROPE, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	20-07-29	AQ
NEUROTROPE, INC. : Other Events (form 8-K)	20-07-24	AQ
NEUROTROPE, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	20-07-24	AQ
Neurotrope : Announces Strategic Partnership with BryoLogyx for Supply of Synthetic Bryostatin-1 and Continuation of the National Cancer Institute Trial for Childhood Leukemia	20-06-15	AQ
NEUROTROPE : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	20-06-12	AQ
Neurotrope, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-06-12	CI
Bryologyx Announces Agreements with Neurotrope to Acquire Bryostatin-1 Immuno-Oncology Data Package, Supply Synthetic Bryostatin-1	20-06-10	CI
NEUROTROPE, INC. : Regulation FD Disclosure, Other Events (form 8-K)	20-05-28	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Neurotrope Inc Other OTC

Equities

US64129T1088

Summary

Filters